γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer.
Frieling JS, Tordesillas L, Bustos XE, Ramello MC, Bishop RT, Cianne JE, Snedal SA, Li T, Lo CH, de la Iglesia J, Roselli E, Benzaïd I, Wang X, Kim Y, Lynch CC, Abate-Daga D.
Frieling JS, et al. Among authors: lo ch.
Sci Adv. 2023 May 3;9(18):eadf0108. doi: 10.1126/sciadv.adf0108. Epub 2023 May 3.
Sci Adv. 2023.
PMID: 37134157
Free PMC article.